- Home
- BQ vs GLMD Comparison
BQ vs GLMD Comparison
Compare BQ & GLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BQ
- GLMD
- Stock Information
- Founded
- BQ 2008
- GLMD 2000
- Country
- BQ China
- GLMD Israel
- Employees
- BQ N/A
- GLMD N/A
- Industry
- BQ Other Specialty Stores
- GLMD Biotechnology: Pharmaceutical Preparations
- Sector
- BQ Consumer Discretionary
- GLMD Health Care
- Exchange
- BQ Nasdaq
- GLMD Nasdaq
- Market Cap
- BQ 5.7M
- GLMD 4.6M
- IPO Year
- BQ 2020
- GLMD 2014
- Fundamental
- Price
- BQ $0.30
- GLMD $2.95
- Analyst Decision
- BQ
- GLMD
- Analyst Count
- BQ 0
- GLMD 0
- Target Price
- BQ N/A
- GLMD N/A
- AVG Volume (30 Days)
- BQ 193.0K
- GLMD 41.8K
- Earning Date
- BQ 12-31-2024
- GLMD 12-27-2024
- Dividend Yield
- BQ N/A
- GLMD N/A
- EPS Growth
- BQ N/A
- GLMD N/A
- EPS
- BQ N/A
- GLMD N/A
- Revenue
- BQ $98,241,396.00
- GLMD N/A
- Revenue This Year
- BQ N/A
- GLMD N/A
- Revenue Next Year
- BQ N/A
- GLMD N/A
- P/E Ratio
- BQ N/A
- GLMD N/A
- Revenue Growth
- BQ N/A
- GLMD N/A
- 52 Week Low
- BQ $0.22
- GLMD $2.56
- 52 Week High
- BQ $0.74
- GLMD $23.80
- Technical
- Relative Strength Index (RSI)
- BQ 30.17
- GLMD 51.13
- Support Level
- BQ $0.32
- GLMD $2.73
- Resistance Level
- BQ $0.38
- GLMD $3.07
- Average True Range (ATR)
- BQ 0.04
- GLMD 0.23
- MACD
- BQ -0.01
- GLMD 0.08
- Stochastic Oscillator
- BQ 0.00
- GLMD 66.69
About BQ Boqii Holding Limited representing
Boqii Holding Ltd operates in the business of selling pet products through online stores. The store provides pet foods, health products, pet grooming products, pet bathing products, pet toys, fish tank, aquatic fertilizer, temperature control equipment, oxygen pump and other related products. Also, the company sells its products through offline channels to pet stores and hospitals.
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.